advertisement
Riva I 11
Showing records 1 to 11 | Display all abstracts from Riva I69177 Latanoprost and Dorzolamide for the Treatment of Pediatric Glaucoma: The Glaucoma Italian Pediatric Study (Gipsy), Design and Baseline Characteristics
Quaranta L
Advances in Therapy 2016; 33: 1305-1315
69418 Twenty-four-hour intraocular pressure and ocular perfusion pressure characteristics in newly diagnosed patients with normal tension glaucoma
Quaranta L; Katsanos A
Eye 2016; 30: 1481-1489
69177 Latanoprost and Dorzolamide for the Treatment of Pediatric Glaucoma: The Glaucoma Italian Pediatric Study (Gipsy), Design and Baseline Characteristics
Biagioli E
Advances in Therapy 2016; 33: 1305-1315
69418 Twenty-four-hour intraocular pressure and ocular perfusion pressure characteristics in newly diagnosed patients with normal tension glaucoma
Riva I
Eye 2016; 30: 1481-1489
69177 Latanoprost and Dorzolamide for the Treatment of Pediatric Glaucoma: The Glaucoma Italian Pediatric Study (Gipsy), Design and Baseline Characteristics
Galli F; Poli D
Advances in Therapy 2016; 33: 1305-1315
69418 Twenty-four-hour intraocular pressure and ocular perfusion pressure characteristics in newly diagnosed patients with normal tension glaucoma
Dastiridou A; Oddone F
Eye 2016; 30: 1481-1489
69177 Latanoprost and Dorzolamide for the Treatment of Pediatric Glaucoma: The Glaucoma Italian Pediatric Study (Gipsy), Design and Baseline Characteristics
Rulli E; Riva I
Advances in Therapy 2016; 33: 1305-1315
69418 Twenty-four-hour intraocular pressure and ocular perfusion pressure characteristics in newly diagnosed patients with normal tension glaucoma
Roberti G
Eye 2016; 30: 1481-1489
69177 Latanoprost and Dorzolamide for the Treatment of Pediatric Glaucoma: The Glaucoma Italian Pediatric Study (Gipsy), Design and Baseline Characteristics
Hollander L
Advances in Therapy 2016; 33: 1305-1315
69418 Twenty-four-hour intraocular pressure and ocular perfusion pressure characteristics in newly diagnosed patients with normal tension glaucoma
Konstas AG
Eye 2016; 30: 1481-1489
69177 Latanoprost and Dorzolamide for the Treatment of Pediatric Glaucoma: The Glaucoma Italian Pediatric Study (Gipsy), Design and Baseline Characteristics
Katsanos A; Longo A; Uva MG; Torri V; Weinreb RN
Advances in Therapy 2016; 33: 1305-1315
